Gérond'if opens REFERENCE-AI trial testing AI echocardiography in geriatric heart failure patients
The French research organization is recruiting for a single-center study comparing AI-assisted and standard echocardiography for measuring ejection fraction in patients 75 and older.
- The trial is recruiting, with an actual start date of July 7, 2026, and heart failure is the leading cause of hospitalization among adults aged 80 years and older.1 The study plans to enroll 130 participants (estimated)1 and compares standard echocardiography against AI-assisted automated LVEF assessment performed by a geriatrician using a handheld ultrasound device and Us2.ai software for automated analysis.1 Primary completion is estimated for June 30, 2028, according to the registry record.
Fact check notes
- Checker's noteThe claim that 'Gérond'if has one active trial listed this week' is not supported by the source; it appears to be an unfounded editorial statement not found in the registry data.
- Sentence removed
Gérond'if has one active trial listed this week, a diagnostic study evaluating an AI tool for cardiac imaging in older adults.
unsupported: The source provides no information about how many trials Gérond'if has active this week or whether this is the only one; this is an unsupported editorial addition. - Sentence removed
REFERENCE-AI (NCT07701369) is a prospective, single-center interventional study comparing two methods of left ventricular ejection fraction measurement in patients aged 75 years and older hospitalized for acute heart failure.
copied source wording
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Where the check questioned a sentence, its note is shown above. Not investment advice.